Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for insulin resistance in genotype 1 hepatitis C patients treated with peginterferon alfa-2a plus ribavirin
2005-002446-19Phase 4Completed
- Sponsor
- Hospital Universitario de Valme
- Start
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of metformin in chronic hepatitis C virus infection and insulin resistance (IR) (2 arms), sponsored by Hospital Universitario de Valme. Primary endpoints: SVR24 and Metformin safety. Started Jul 2005; status: completed.
02
Drugs
metformin
03
Conditions
chronic hepatitis C virus infectioninsulin resistance (IR)
Beyond the preview
Go deeper on 2005-002446-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002446-19.